Trials / Completed
CompletedNCT06508541
The Prognosis of Colorectal Cancer Patients After Indocyanine Green Fluorescence-guided Radical Surgery
The Prognosis of Colorectal Cancer Patients After Indocyanine Green Fluorescence-guided Radical Surgery: a Retrospective Cohort Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 235 (actual)
- Sponsor
- Shanghai Tong Ren Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Previous studies of Indocyanine green (ICG) in colorectal surgery have focused on lymphatic mapping, lymph node detection, and the number of harvested lymph nodes. However, relatively few studies have evaluated the outcomes of this imaging technology, especially the prognosis following of colorectal cancer resection. The present study assessed the prognosis of colorectal cancer patients following ICG fluorescence-guided surgery as compared to conventional surgery without the use of ICG Fluorescence imaging
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | ICG Guided surgery | In ICG guided surgery group,Approximately 0.3 ml of ICG dissolved in 2.5 mg/ml of sterile water was injected submucosally by the endoscopic doctors through colonoscopy at two points around the tumor.All patients underwent standard complete mesocolic excision (CME) or total mesorectal excision (TME) with curable purpose using ICG lymphangiography procedure |
| PROCEDURE | conventional surgery | All patients underwent standard complete mesocolic excision (CME) or total mesorectal excision (TME) with curable purpose |
Timeline
- Start date
- 2024-07-15
- Primary completion
- 2024-10-01
- Completion
- 2024-10-01
- First posted
- 2024-07-18
- Last updated
- 2024-12-16
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06508541. Inclusion in this directory is not an endorsement.